|
Molecular properties generated using the CDK |
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1995), EMA (2006)) |
IUPAC Name ![]() |
6-hydroxy-4-[(2S)-2-(5-hydroxy-3-oxo-1,2,3,6-tetrahydropyrazin-1-yl)propyl]-2,3,4,5-tetrahydropyrazin-2-one |
International Nonproprietary Names ![]() |
|
INN number | INN |
6544 | dexrazoxane |
Synonyms ![]() |
ADR-529 | Cardioxane® | ICRF-187 | Zinecard® |
Database Links ![]() |
|
CAS Registry No. | 24584-09-6 |
ChEMBL Ligand | CHEMBL1738 |
DrugBank Ligand | DB00380 |
GtoPdb PubChem SID | 178103902 |
PubChem CID | 71384 |
Search Google for chemical match using the InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
Search Google for chemicals with the same backbone | BMKDZUISNHGIBY |
Search PubMed clinical trials | dexrazoxane |
Search PubMed titles | dexrazoxane |
Search PubMed titles/abstracts | dexrazoxane |
Search UniChem for chemical match using the InChIKey | BMKDZUISNHGIBY-ZETCQYMHSA-N |
Search UniChem for chemicals with the same backbone | BMKDZUISNHGIBY |
Wikipedia | Dexrazoxane |
Comments |
Dexrazoxane is an EDTA derivative with iron-chelating activity. |